Nightstar

Acquired

Nightstar is a biotech company in Oxford, United Kingdom, founded in 2014. It has raised $99.1M across 4 rounds, most recently a $45.0M Series C in June 2017.

Headquarters
Oxford
Employees
51–200
Founded
2014
Business Model
B2B
Total Funding
$99.1M
Last Round
$45.0M Series CJun 2017
Rounds
4
Acquired by
BiogenJun 2019 · $800.0M

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds for this company. The full record is or through the API.

About

Nightstar Therapeutics was an Oxford University spinout developing adeno-associated virus (AAV) gene therapies for inherited retinal diseases including choroideremia and retinitis pigmentosa. Founded in 2014, it completed a NASDAQ IPO in 2017 and was acquired by Biogen for approximately $800 million in June 2019.

Summary

It lists 51–200 employees. It has raised $99.1M in total across 4 rounds, most recently a $45.0M Series C round in Jun 2017.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionJun 2019

Sign up to see all 6 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nightstar on Indexed.vc
<a href="https://indexed.vc/companies/nightstar"><img src="https://indexed.vc/api/badge/company/nightstar" alt="Nightstar on Indexed.vc" width="260" height="76" /></a>